Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction

T. Uematsu,F. Follath,S. Vožeh

DOI: https://doi.org/10.1007/BF00541534

European Journal of Clinical Pharmacology

Abstract:

What problem does this paper attempt to address?

Vibrio vulnificus metalloprotease VvpE has no direct effect on the iron-assimilation from human holotransferrin.

Sung-Heui Shin,Hui-yu Sun,Ra-Young Park,Choon-Mee Kim,S. Kim,J. Rhee

DOI: https://doi.org/10.1016/J.FEMSLE.2005.05.015

2005-06-01

FEMS Microbiology Letters

Abstract:
[Rheumatoid Leptomeningitis: a Case Report and Literature Review].

Ri-liang Zheng,He Lv,Wei Zhang,Min-xuan Yu,Yun Yuan

DOI: https://doi.org/10.3321/j.issn:1671-167x.2006.03.024

2006-01-01

Abstract:To report the clinical, radiological and neuropathological findings of a patient with rheumatoid meningitis. The patient was a 71-year-old Chinese man with a two-year history of rheumatoid arthritis and no other significant medical history, who presented to our hospital recurrent weakness of his left extremities, dysarthria and a continuous bilateral hand tremor. Cerebrospinal fluid (CSF) and serum examinations were normal apart from a mildly raised serum perinuclear antineutrophil cytoplasmic autoantibody (p-ANCA). Brain magnetic resonance imaging (MRI) showed leptomeningeal enhancement in both frontal and parietal lobes, in addition to several old white matter infarcts. Meningeal biopsy showed numerous infiltrating macrophages and lymphocytes within the leptomeninges. The patient responded clinically and radiologically to corticosteroid and cyclophosphamide therapy. The patient subsequently developed herpes zoster over his left chest as a complication of his immunosuppressive treatment. His cyclophosphamide was ceased and intravenous immunoglobulin (IVIG) therapy was commenced, with good clinical response to both the herpes zoster and meningitis. According to the result of the biopsy, aseptic meningitis was considered the MRI results and the patient's clinical history were given, and a diagnosis of rheumatoid meningitis was made. The patient was p-ANCA positive. Although there was no evidence for cerebral vasculitis on biopsy, it remains a possibility that the patient's recurrent minor cerebral infarcts visible on MRI were vasculitic in nature.
[Physiopathology of pulmonary pressure].

L. Condorelli

1951-09-01

Abstract:
Anti-NMDAR encephalitis in Crohn’s disease undergoing long-term infliximab treatment: A case report

Shin Ju Oh,Young Nam Kwon,Chang Kyun Lee,Jin San Lee

DOI: https://doi.org/10.3389/fimmu.2022.957575

IF: 7.3

2022-10-31

Frontiers in Immunology

Abstract:Infliximab, a chimeric monoclonal antibody against anti-tumor necrosis factor-α (TNF-α), has revolutionized the management of inflammatory bowel disease. However, a recent nested case-control study showed that anti-TNF-α therapy exposure in patients with autoimmune diseases is associated with an increased risk of inflammatory central nervous system (CNS) events. A 27-year-old man diagnosed with Crohn’s disease at 17 years of age was referred to our clinic for suffering with Wernicke’s aphasia and the right-hand weakness over two weeks. Nine years of treatment for Crohn’s disease with infliximab anti-TNF-α therapy was well tolerated. An initial MRI revealed diffuse leptomeningeal enhancement along the bilateral cerebral sulci without any parenchymal abnormalities. Cerebrospinal fluid (CSF) and serum N-methyl-D-aspartate receptor (NMDAR) antibody testing yielded positive results. Anti-NMDAR encephalitis was diagnosed, and the patient was treated with rituximab. A follow-up brain MRI showed new multiple cerebral lesions in the left insular cortex and subcortical white matter of the left frontal and temporal gyri. Approximately 8 months after symptom onset, the CSF and serum NMDAR antibody converted to negative. Twelve months later, the patient fully recovered from anti-NMDAR encephalitis without any neurological deficits and is currently being treated with the anti-interleukin 12/23 agent ustekinumab for Crohn’s disease. This is the first report of not only a patient with infliximab-associated anti-NMDAR encephalitis in Crohn’s disease but also of an inflammatory non-demyelinating CNS event during long-term suppression of TNF-α. Our case highlights the need for clinicians to recognize the possibility of a paradoxical autoimmune response occurring with novel biological therapies.

immunology
Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review

Massimiliano Castellazzi,Raffaella Candeloro,Maura Pugliatti,Marcello Govoni,Ettore Silvagni,Alessandra Bortoluzzi

DOI: https://doi.org/10.3390/diagnostics14030242

IF: 3.6

2024-01-24

Diagnostics

Abstract:The analysis of cerebrospinal fluid (CSF) remains a valuable diagnostic tool in the evaluation of inflammatory and infectious conditions involving the brain, spinal cord, and meninges. Since many rheumatic inflammatory diseases can involve the central and peripheral nervous system, the aims of this narrative review were to summarize the latest evidence on the use of CSF analysis in the field of neuropsychiatric manifestations of rheumatic diseases. Routine CSF parameters were taken into consideration for this review: appearance; total protein and cellular content (pleocytosis); lactate and/or glucose; CSF/serum albumin quotient; intrathecal synthesis of IgG. Data regarding the role of CSF analysis in the clinical management of neuropsychiatric systemic lupus erythematosus, primary Sjogren's syndrome, rheumatoid arthritis, and Behçet's syndrome are presented. Although no disease-specific picture has been identified, CSF analysis remains a useful diagnostic tool to confirm the presence of a neuro-inflammatory state or, conversely, to exclude the concomitant presence of other inflammatory/infectious diseases affecting the CNS in the context of systemic rheumatologic conditions.

medicine, general & internal
The micro-structure of tapping movements in children.

J. Schellekens,A. Kalverboer,C. Scholten

DOI: https://doi.org/10.1080/00222895.1984.10735309

1984-03-01

Journal of Motor Behavior

Abstract:In order to investigate the development of movement speed in relation to movement organization, children of 5, 6, 7, 8 and 9 years of age and adults carried out a reciprocal tapping task, in which time pressure and distance were manipulated. The duration, velocity, acceleration and accuracy of the movements were compared between age groups. Age differences appeared mainly in the homing time, not in the duration of the distance covering movement phase. Accuracy and velocity of the distance covering movement phase differed with age. Time pressure affected the homing time, but not the duration of the distance covering phase. Distance manipulation affected mainly the velocity and duration of the distance covering movement phase and the homing time. In the discussion it is contended that age differences in homing time may be related to both the accuracy of the distance covering movement phase and the rate of information processing of the subject.
Teaching Power Electronics using the switching function approach

C. Marouchos,M. Darwish

DOI: https://doi.org/10.1109/UPEC.2012.6398595

2012-12-31

Abstract:The teaching of Power Electronics at university Level can be simplified and can be more effective by employing the Switching Function Technique. A unified approach to the operation and analysis of any power converter circuit is possible. The authors tried this approach for a number of years at the Cyprus University of Technology and at Brunel University. This teaching approach is based on the identification of the appropriate switching function which can be applied to a power converter. The switching function is a series of pulses of unity magnitude and it is expressed as a series of sinusoids and its parameters are the ON period of the pulses as well as their phase angles. Analytical expressions of current and voltage waveforms are derived at any point of the circuit -preferably the input and output- as a series of sinusoids. This makes the identification of the order of the harmonics straightforward and the calculation of harmonic magnitude & phase, THD, PF etc. possible.
Cerebral Tumefactive Inflammatory Lesion Occurrence During Ixekizumab Treatment in a Patient With Active Psoriatic Arthritis

Antonio Marangi,Francesco Benvenuti,Linda Mazzai,Giulio Riva,Diana Polo,Ilaria Franceschetti,Pierino De Sandre,Mariano Agostino Zanusso,Giovanni Scanelli,Francesco Perini

DOI: https://doi.org/10.1097/nrl.0000000000000551

2024-01-22

The Neurologist

Abstract:Introduction: Ixekizumab is an anti–interleukin-17A (IL-17A) humanized monoclonal antibody approved for the treatment of moderate-to-severe plaque psoriasis, active psoriatic arthritis, and ankylosing spondylitis. Central nervous system inflammatory manifestations are atypical during therapy with IL-17A inhibitors, with only one case of myelitis described to date. Case report: A 72-year-old man with a medical history of active psoriatic arthritis was admitted to our department owing to the acute onset of left face numbness 1 month after the first ixekizumab administration. Magnetic resonance imaging of the brain displayed a large T2-hyperintense infratentorial lesion involving the root of the fifth and seventh left cranial nerves. A thorough laboratoristic and instrumental work-up did not show elements suggestive of extracerebral neoplasms or infections. Therefore, neuronavigation-assisted brain biopsy was performed, and histologic analysis of the lesion revealed the presence of wide aggregates of foamy histiocytes diffusely infiltrating the brain parenchyma, in the absence of malignant tissue or histologic elements suggestive of central nervous system infections or primary histiocytoses. Steroid treatment (dexamethasone 8 mg/daily) was then administered with subsequent clinical amelioration. One month after hospital discharge, a brain magnetic resonance imaging showed a nearly complete resolution of the lesion. Conclusion: This is the first case of a cerebral inflammatory lesion occurring during treatment with ixekizumab. Although very rare, neurological complications may occur during anti–IL-17A therapies, thus leading to the need for careful monitoring of patients exposed to these drugs.

clinical neurology
The spatial transcript: analysing mobilities through qualitative GIS

Phil I. Jones,James Evans

DOI: https://doi.org/10.1111/J.1475-4762.2011.01058.X

2012-03-01

Abstract:This paper identifies a failure by mobilities scholars to engage with the methodological and analytical possibilities offered by qualitative GIS. We argue this represents a missed opportunity and present the spatial transcript, a technique we have developed in order to address this shortcoming. Qualitative GIS seeks to find ways to analyse how space shapes data, offering a useful way in to investigating the mobile body. The spatial transcript allows researchers to engage in a process of grounded visualisation in order to analyse interview data in the context of the location in which it was gathered. We conclude that this technique offers valuable insights into the ways that space and mobilities are co-constructed.
Reachability analysis of shipboard power systems with uncertain pulsed loads

Hugo N. Villegas Pico,D. Aliprantis,S. Sudhoff

DOI: https://doi.org/10.1109/ESTS.2015.7157925

2015-06-21

Abstract:This paper presents a computational technique to analyze the impact of uncertain pulsed loads on shipboard power systems. The method is suitable for conducting studies at the design stage, when modeling details can be sparse. The capability of the system to remain within operational specifications when subjected to unknown-but-bounded pulsed loads is investigated. The analysis yields bounds that are guaranteed to contain the trajectories of all possible disturbance scenarios.
Multiple Sclerosis - Like Demyelinating Lesions During Adalimumab Treatment in a Case with Crohn's Disease

Okan Sökmen,Rahşan Göçmen,Aslı Tuncer

DOI: https://doi.org/10.29399/npa.27973

2022-02-21

Abstract:Tumor necrosis factor (TNF) antagonists have made significant progress in treating autoimmune diseases like inflammatory bowel disease. Adalimumab, a human anti-TNF monoclonal antibody, may be a treatment option for patients with moderate to severe Crohn's disease for whom conventional treatments have not been effective. Central nervous system (CNS) and peripheral nervous system (PNS) demyelination may rarely develop during treatment. However, it is unclear whether CNS and PNS demyelination occurs as a coincidence or consequence. This report presents a 45-year-old male patient who developed multiple sclerosis-like demyelinating lesions at the seventh month of TNF alpha-blocker treatment. We discontinued anti-TNF therapy and initiated azathioprine. In the approximately eighteen-month follow-up, he did not show any neurological or radiological deterioration. When the autoimmune disease develops during anti-TNF blocker therapy, it would be a safe approach to choose a different group of biologic agents for disease control. The potential risk of developing neurological side effects requires closely follow-up of patients.
TNFR2 Deficiency Acts in Concert with Gut Microbiota To Precipitate Spontaneous Sex-Biased Central Nervous System Demyelinating Autoimmune Disease

Patrick G Miller,Michael B Bonn,Craig L Franklin,Aaron C Ericsson,Susan C McKarns

DOI: https://doi.org/10.4049/jimmunol.1501664

2015-11-15

Abstract:TNF-α antagonists provide benefit to patients with inflammatory autoimmune disorders such as Crohn's disease, rheumatoid arthritis, and ankylosing spondylitis. However, TNF antagonism unexplainably exacerbates CNS autoimmunity, including multiple sclerosis and neuromyelitis optica. The underlying mechanisms remain enigmatic. We demonstrate that TNFR2 deficiency results in female-biased spontaneous autoimmune CNS demyelination in myelin oligodendrocyte glycoprotein-specific 2D2 TCR transgenic mice. Disease in TNFR2(-/-) 2D2 mice was associated with CNS infiltration of T and B cells as well as increased production of myelin oligodendrocyte glycoprotein-specific IL-17, IFN-γ, and IgG2b. Attenuated disease in TNF(-/-) 2D2 mice relative to TNFR2(-/-) 2D2 mice identified distinctive roles for TNFR1 and TNFR2. Oral antibiotic treatment eliminated spontaneous autoimmunity in TNFR2(-/-) 2D2 mice to suggest role for gut microbiota. Illumina sequencing of fecal 16S rRNA identified a distinct microbiota profile in male TNFR2(-/-) 2D2 that was associated with disease protection. Akkermansia muciniphila, Sutterella sp., Oscillospira sp., Bacteroides acidifaciens, and Anaeroplasma sp. were selectively more abundant in male TNFR2(-/-) 2D2 mice. In contrast, Bacteroides sp., Bacteroides uniformis, and Parabacteroides sp. were more abundant in affected female TNFR2(-/-) 2D2 mice, suggesting a role in disease causation. Overall, TNFR2 blockade appears to disrupt commensal bacteria-host immune symbiosis to reveal autoimmune demyelination in genetically susceptible mice. Under this paradigm, microbes likely contribute to an individual's response to anti-TNF therapy. This model provides a foundation for host immune-microbiota-directed measures for the prevention and treatment of CNS-demyelinating autoimmune disorders.
Multiple sclerosis in a patient with Takayasu's Arteritis: A case report

Mohammad Mehdi Emam,Mahdiye Abiyarghamsari,Muhanna Kazempour,Maryam Haghighi-Morad,Farane Farsad

DOI: https://doi.org/10.22088/cjim.15.4.729

2024-09-07

Abstract:Background: Multiple sclerosis (MS) and Takayasu's arteritis (TAK) are two autoimmune diseases that affect the Central nervous system (CNS), but the relationship between them has not been established. Case presentation: Here we report the emergence of MS during treatment. Takayasu's arteritis in a 24-year-old Iranian woman with a severe presentation. She was treated aggressively with IV methylprednisolone 1 g/day for 3 days and continued with oral prednisolone, also IV cyclophosphamide monthly. After 2 months, loss of vision led to a diagnosis of Optic neuritis (ON) caused by concomitant MS. Conclusion: Differentiating CNS vasculitis associated with Takayasu's arthritis from coexisting MS affecting the CNS is challenging and what is important is to avoid giving a TNF inhibitor.
Coexisting of Meningoencephalitis with Spondyloarthritis: A Case Report

Xue Yang,Jian Wang,Yue Zhang

DOI: https://doi.org/10.1016/j.nerep.2022.100059

2022-01-01

Neuroimmunology Reports

Abstract:Spondyloarthritis (SpA) is characterized by inflammation at the axial skeleton, peripheral joints, and entheses. Central nervous system involvement is uncommon for SpA. We describe a 54-year-old male with untreated SpA presenting with headache, malaise and fever for 17 days. Intracranial pressure was high. CSF analysis revealed slight pleocytosis. Brain MRI showed hyperintense signals in the frontoparietal lobe and corpus callosum. HLA-B27 was positive in the serum. HIs symptom improved after corticotherapy. This is the first reported case of concomitant SpA and meningoencephalitis. Further studies are needed to elucidate the association between the two diseases.
Anti-NMDAr Encephalitis and COVID-19 in a Patient With Systemic pANCA-Vasculitis and Recurrent Varicella Zoster Infection

João Moura,Sara Duarte,Ana Sardoeira,João Neves-Maia,Joana Damásio,Ricardo Taipa,Paula Carneiro,Esmeralda Neves,Ana Campar,Ernestina Santos

DOI: https://doi.org/10.1177/19418744211063709

2022-01-10

The Neurohospitalist

Abstract:Introduction There is a complex interplay between systemic autoimmunity, immunosuppression, and infections. Any or all of these can result in neurologic manifestations, requiring diligence on the part of neurologists. Case report We herein report a case of a patient on immunosuppressive treatment for a vasculitis that resulted in zoster meningoencephalitis. This was further complicated by the development of anti-NMDAr encephalitis, the etiology of which is undetermined and further discussed in this paper. The patient eventually developed COVID-19 during hospitalization, succumbing to the respiratory infection. Conclusion This case emphasizes that post-infectious autoimmune disorders are becoming increasingly recognized and that they should still be considered in patients who are on immunosuppression. Practitioners should be aware of the complex relationship between autoimmunity and immunosuppression and consider both throughout the disease course.
Case report: A case of anti-glycine receptor encephalomyelitis triggered by post-transplant or COVID-19 infection?

Zhengxue Zhang,Xiang Zhang,Mingming Dai,Yingying Wu,Yong You

DOI: https://doi.org/10.3389/fneur.2024.1356691

IF: 3.4

2024-04-19

Frontiers in Neurology

Abstract:Even though long-term immunosuppressant drugs (ISD) are employed to inhibit immune system activity, enhancing graft functionality and patient survival in solid organ transplantation (SOT), these transplants often lead to immune complications, with post-transplant autoimmune diseases of the central nervous system (CNS) being uncommon. Here, we detail the case of a 66-year-old woman who underwent a renal transplantation 8 months prior, who was admitted with subacute onset of encephalomyelitis, accompanied by headaches, paraplegia, weakness, vomiting, and abdominal pain, with a positive COVID-19 nasopharyngeal swab test 1 month before admission. MRI scans of the brain revealed multiple lesions in the white matter of the bilateral deep frontal lobe, the left temporal lobe and insula lobe. Additionally, there were multiple short segment lesions in the spinal cord and subdural hematoma at T1, T6-T7 posterior. The serum revealed a positive result for GlyR-IgG. Following the administration of corticosteroid and intravenous immunoglobulin, there was a significant improvement in the patient's symptoms within 2 weeks, and her brain MRI showed a reduction in the lesion. Despite its rarity, we believe this to be the inaugural documentation of anti-GlyR encephalomyelitis occurring during renal transplantation. A full panel of antibodies for autoimmune encephalomyelitis is the key leading to the diagnosis.

neurosciences,clinical neurology
Emergence of acute quadriparesis in a young patient following myocardial infarction. A case report

Sajjad Daneshyar,Mojtaba Khazaei,Mozhgan Nazifi

DOI: https://doi.org/10.1002/ccr3.9366

2024-08-27

Abstract:Cerebrovascular events are closely related to cardiac events. Chronic inflammatory diseases, such as rheumatoid arthritis (RA), increase the risk of cardiovascular and cerebrovascular stroke. The link between RA, myocardial infarction, and resulting neurological issues highlights the case's complexity, stressing the need for a comprehensive, interdisciplinary medical approach.
Familial persistent müllerian duct syndrome.

M. Beheshti,B. Churchill,B. Hardy,J. Bailey,R. Weksberg,George F. Rogan

DOI: https://doi.org/10.1016/S0022-5347(17)50733-8

1984-05-01

Abstract:
Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice

Jon Lampa,Marie Westman,Diana Kadetoff,Anna Nordenstedt Agréus,Erwan Le Maître,Caroline Gillis-Haegerstrand,Magnus Andersson,Mohsen Khademi,Maripat Corr,Christina A. Christianson,Ada Delaney,Tony L. Yaksh,Eva Kosek,Camilla I. Svensson

DOI: https://doi.org/10.1073/pnas.1118748109

IF: 11.1

2012-07-16

Proceedings of the National Academy of Sciences

Abstract:During peripheral immune activation caused by an infection or an inflammatory condition, the innate immune response signals to the brain and causes an up-regulation of central nervous system (CNS) cytokine production. Central actions of proinflammatory cytokines, in particular IL-1β, are pivotal for the induction of fever and fatigue. In the present study, the influence of peripheral chronic joint inflammatory disease in rheumatoid arthritis (RA) on CNS inflammation was investigated. Intrathecal interleukin (IL)-1β concentrations were markedly elevated in RA patients compared with controls or with patients with multiple sclerosis. Conversely, the anti-inflammatory IL-1 receptor antagonist and IL-4 were decreased in RA cerebrospinal fluid (CSF). Tumor necrosis factor and IL-6 levels in the CSF did not differ between patients and controls. Concerning IL-1β, CSF concentrations in RA patients were higher than in serum, indicating local production in the CNS, and there was a positive correlation between CSF IL-1β and fatigue assessments. Next, spinal inflammation in experimental arthritis was investigated. A marked increase of IL-1β, IL-18, and tumor necrosis factor, but not IL-6 mRNA production, in the spinal cord was observed, coinciding with increased arthritis scores in the KBxN serum transfer model. These data provide evidence that peripheral inflammation such as arthritis is associated with an immunological activation in the CNS in both humans and mice, suggesting a possible therapeutic target for centrally affecting conditions as fatigue in chronic inflammatory diseases, for which to date there are no specific treatments.

multidisciplinary sciences
Risk of Inflammatory Central Nervous System Diseases After Tumor Necrosis Factor-Inhibitor Treatment for Autoimmune Diseases: A Systematic Review and Meta-Analysis

Wenhui Xie,Yunchuang Sun,Wei Zhang,Nanbo Zhu,Shiyu Xiao

DOI: https://doi.org/10.1001/jamaneurol.2024.3524

2024-12-01

Abstract:Importance: Tumor necrosis factor (TNF) inhibitors have been used extensively to treat various autoimmune diseases. However, there are ongoing debates about the risk of inflammatory central nervous system (CNS) disease events following TNF inhibitor therapy, as well as uncertainty about how this risk varies across different autoimmune diseases or TNF-blocking agents. Objective: To evaluate the risk of inflammatory CNS diseases after anti-TNF initiation and assess the difference in risk among different types of underlying autoimmune diseases or TNF inhibitors. Data sources: Separate searches were conducted across PubMed, Embase, and the Cochrane Library from inception until March 1, 2024. Study selection: Observational studies assessing the association between anti-TNF therapy and inflammatory CNS diseases relative to a comparator group. Data extraction and synthesis: Study eligibility assessment and data extraction were independently conducted by 2 investigators following PRISMA guidelines. The risk ratio (RR) was used as the effect measure of the pooled analysis. Main outcomes and measures: The primary outcome was the risk of incident inflammatory CNS events after anti-TNF therapy for autoimmune diseases. Secondary analyses were performed based on different types of underlying autoimmune diseases and TNF inhibitors. Results: Eighteen studies involving 1 118 428 patients with autoimmune diseases contributing more than 5 698 532 person-years of follow-up were analyzed. The incidence rates of new-onset inflammatory CNS events after initiating TNF inhibitors ranged from 2.0 to 13.4 per 10 000 person-years. Overall, exposure to TNF inhibitors was associated with a 36% increased risk of any inflammatory CNS disease compared to conventional therapies (RR, 1.36; 95% CI, 1.01-1.84; I2, 49%), mainly attributed to demyelinating diseases (RR, 1.38; 95% CI, 1.04-1.81; I2, 31%). Secondary analyses revealed a similar risk of inflammatory CNS diseases across different types of underlying autoimmune diseases (rheumatic diseases: RR, 1.36; 95% CI, 0.84-2.21; inflammatory bowel disease 1.49; 95% CI, 0.93-2.40; P for subgroup = .74) and TNF inhibitors (anti-TNF monoclonal antibodies vs etanercept: RR, 1.04; 95% CI, 0.93-1.15; I2, 0%). Conclusions and relevance: Compared to conventional therapies, exposure to TNF inhibitors was associated with a 36% increased risk of inflammatory CNS diseases, irrespective of background autoimmune disease or TNF inhibitor type.

Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction

Vibrio vulnificus metalloprotease VvpE has no direct effect on the iron-assimilation from human holotransferrin.

[Rheumatoid Leptomeningitis: a Case Report and Literature Review].

[Physiopathology of pulmonary pressure].

Anti-NMDAR encephalitis in Crohn’s disease undergoing long-term infliximab treatment: A case report

Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review

The micro-structure of tapping movements in children.

Teaching Power Electronics using the switching function approach

Cerebral Tumefactive Inflammatory Lesion Occurrence During Ixekizumab Treatment in a Patient With Active Psoriatic Arthritis

The spatial transcript: analysing mobilities through qualitative GIS

Reachability analysis of shipboard power systems with uncertain pulsed loads

Multiple Sclerosis - Like Demyelinating Lesions During Adalimumab Treatment in a Case with Crohn's Disease

TNFR2 Deficiency Acts in Concert with Gut Microbiota To Precipitate Spontaneous Sex-Biased Central Nervous System Demyelinating Autoimmune Disease

Multiple sclerosis in a patient with Takayasu's Arteritis: A case report

Coexisting of Meningoencephalitis with Spondyloarthritis: A Case Report

Anti-NMDAr Encephalitis and COVID-19 in a Patient With Systemic pANCA-Vasculitis and Recurrent Varicella Zoster Infection

Case report: A case of anti-glycine receptor encephalomyelitis triggered by post-transplant or COVID-19 infection?

Emergence of acute quadriparesis in a young patient following myocardial infarction. A case report

Familial persistent müllerian duct syndrome.

Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice

Risk of Inflammatory Central Nervous System Diseases After Tumor Necrosis Factor-Inhibitor Treatment for Autoimmune Diseases: A Systematic Review and Meta-Analysis